UroGen Pharma
URGN
URGN
64 hedge funds and large institutions have $115M invested in UroGen Pharma in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.18% less ownership
Funds ownership: 58.58% → 56.4% (-2.2%)
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
Holders
64
Holding in Top 10
1
Calls
$1.25M
Puts
$4K
Top Buyers
| 1 | +$1.6M | |
| 2 | +$809K | |
| 3 | +$481K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$346K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$312K |
Top Sellers
| 1 | -$2.78M | |
| 2 | -$1.44M | |
| 3 | -$752K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$448K |
| 5 |
E
Ergoteles
New York
|
-$380K |